3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
69
Carcinoma, Non-Small-Cell Lung
62
Stomach Neoplasms
32
Prostatic Neoplasms
21
Nasopharyngeal Carcinoma
20
Lung Neoplasms
20
Squamous Cell Carcinoma of Head and Neck
11
Esophageal Neoplasms
11
Neoplasm Metastasis
8
Head and Neck Neoplasms
7
Inflammatory Breast Neoplasms
6
Pancreatic Neoplasms
5
Neoplasms
5
HER2-positive Breast Cancer
5
Adenocarcinoma
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
NSCLC
4
Carcinoma, Squamous Cell
4
Sarcoma
3
Nasopharyngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma, Ovarian Epithelial
3
Breast Diseases
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Tongue Neoplasms
2
Squamous Cell Lung Cancer
2
Interventions
Oxaliplatin
4
Gemcitabine
4
Fluorouracil
3
Capecitabine
3
Tegafur
2
Stents
2
Radiofrequency Ablation
2
Leucovorin
2
Irinotecan
2
toripalimab
1
tislelizumab
1
taxane
1
surufatinib
1
lenvatinib
1
apixaban
1
apatinib
1
aldesleukin
1
Urination
1
Trastuzumab
1
Tomography, X-Ray Computed
1
Temozolomide
1
Taxes
1
Standard of Care
1
Sorafenib
1
S 1 (combination)
1
Rivaroxaban
1
Radiotherapy
1
Polymerase Chain Reaction
1
Platinum Compounds
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Gallbladder Neoplasms
×
Docetaxel
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled